Lipidomic Profiling Identifies Signatures of Poor Cardiovascular Health.

Autor: Rivas Serna IM; International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic., Sitina M; International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic., Stokin GB; International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic., Medina-Inojosa JR; Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55902, USA.; Marriot Heart Disease Research Program, Rochester, MN 55902, USA., Lopez-Jimenez F; Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55902, USA., Gonzalez-Rivas JP; International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic.; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Vinciguerra M; International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic.
Jazyk: angličtina
Zdroj: Metabolites [Metabolites] 2021 Oct 29; Vol. 11 (11). Date of Electronic Publication: 2021 Oct 29.
DOI: 10.3390/metabo11110747
Abstrakt: Ideal cardiovascular health (CVH) is defined for the presence of ideal behavioral and health metrics known to prevent cardiovascular disease (CVD). The association of circulatory phospho- and sphingo-lipids to primary reduction in cardiovascular risk is unclear. Our aim was to determine the association of CVH metrics with the circulating lipid profile of a population-based cohort. Serum sphingolipid and phospholipid species were extracted from 461 patients of the randomly selected prospective Kardiovize study based on Brno, Czech Republic. Lipids species were measured by a hyphenated mass spectrometry technique, and were associated with poor CVH scores, as defined by the American Heart Association. Phosphatidylcholine (PC), phosphatidylethanolamine (PE), lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE) species were significantly lower in ideal and intermediate scores of health dietary metric, blood pressure, total cholesterol and blood fasting glucose compared to poor scores. Current smokers presented higher levels of PC, PE and LPE individual species compared to non-smokers. Ceramide (Cer) d18:1/14:0 was altered in poor blood pressure, total cholesterol and fasting blood glucose metrics. Poor cardiovascular health metric is associated with a specific phospho- and sphingolipid pattern. Circulatory lipid profiling is a potential biomarker to refine cardiovascular health status in primary prevention strategies.
Databáze: MEDLINE